SCHEMBL29925538

SCHEMBL29925538

Cc1ccc(-c2cn3cc(C(=O)O)sc3n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 11/20 0.53
TP53 P04637 6/20 0.53
THRB P10828 1/20 0.53
F2RL3 Q96RI0 1/20 0.48
RAB9A P51151 8/20 0.47
NPC1 O15118 7/20 0.47
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MITF O75030 1/20 0.47
KDM5A P29375 1/20 0.47
KDM5C P41229 1/20 0.47
PAX8 Q06710 1/20 0.47
ALDH1A3 P47895 2/20 0.46
SLC2A1 P11166 1/20 0.46
MAPT P10636 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29925367 0.87 SMN1; SMN2 (0.48) SMN1; SMN2TP53THRBF2RL3RAB9A
SCHEMBL5012213 0.86 TP53 (0.50) SMN1; SMN2TP53THRBF2RL3RAB9A
SCHEMBL1033020 0.85 TP53 (0.57) SMN1; SMN2TP53THRBF2RL3RAB9A
SCHEMBL27362665 0.85 TP53 (0.50) SMN1; SMN2TP53THRBRAB9ANPC1
SCHEMBL7498217 0.83 TP53 (0.42) SMN1; SMN2TP53THRBRAB9ANPC1
SCHEMBL29924707 0.82 MAPT (0.53) SMN1; SMN2TP53THRBF2RL3RAB9A
SCHEMBL27361295 0.80 KMT2A (0.51) SMN1; SMN2TP53RAB9ANPC1KDM4E
SCHEMBL12997562 0.80 SMN1; SMN2 (0.57) SMN1; SMN2TP53THRBF2RL3RAB9A
SCHEMBL27362944 0.79 SMN1; SMN2 (0.41) SMN1; SMN2TP53THRBRAB9ANPC1
SCHEMBL2998562 0.77 WDR91 (0.44) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274569-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2023-11-15 EP disclosed
CN-116635028-A Modulators of c-MYC mRNA translation and their use in the treatment of cancer 艾尼莫生物科技公司 2023-08-22 CN disclosed
WO-2022150316-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2022-07-14 WO disclosed